10 likes | 118 Vues
This figure illustrates the experimental outcomes of siRNA treatment on various ovarian cancer cell lines, including SKOV-3, OVCA432, OVCAR3, and their effect on target gene expression. The average results from three independent experiments were recorded, showing varying levels of gene silencing at percentages of 79.75%, 15.18%, and 92.4%. Importantly, no Ct values were detected in up to 40 cycles of qPCR for some samples, highlighting the efficacy of the siRNA approach in understanding gene function in ovarian cancer.
E N D
Desjardins, et. al., Supplementary Figure 1 A SKOV-3 OVCA432 OVCAR3 p53 β-tubulin B Non-transfected Control siRNA VCAN siRNA 79.75% 15.18% 92.4% C *Presented is an average of three independent experiments performed in triplicate **No Ct values were measured in up to 40 cycles of QPCR